Pharmacological investigation of a new orally active antiarrhythmic drug Su-13197.
D031841:Aconitum; D000818:Animals; D001552:Benzazepines / Q000008:administration & dosage / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D004285:Dogs; D004562:Electrocardiography; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D007093:Imidazoles / Q000008:administration & dosage / Q000627:therapeutic use; D010210:Papillary Muscles / Q000187:drug effects; D010477:Perfusion; D011342:Procainamide / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D013997:Time Factors; D014693:Ventricular Fibrillation / Q000139:chemically induced / Q000188:drug therapy*
D001552:Benzazepines; D007093:Imidazoles; D011802:Quinidine; D011342:Procainamide